Crow Point Partners’s Sanofi SNY Stock Holding History

Crow Point Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-261	Closed	-$10K	–	310
2016 Q3	$10K	Buy	+261	New	+$10.5K	﹤0.01%	303

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Crow Point Partners's SNY Position: Q4 2016 in Review

Crow Point Partners sold out of Sanofi (SNY) in Q4 2016, closing a stake of 261 shares — an estimated $10K sold.

Crow Point Partners first reported a position in SNY in Q3 2016 and held it in 1 quarter. The position peaked at $10K in Q3 2016. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

Crow Point Partners reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
Crow Point Partners sold 261 Sanofi shares in Q4 2016, an estimated $10K.
Crow Point Partners first reported a position in Sanofi in Q3 2016 and held it in 1 quarter.
Crow Point Partners's Sanofi position peaked at $10K in Q3 2016.
476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Crow Point Partners's 13F filing for Q4 2016, filed 15 Feb 2017.